Research
Mixed
Traditional probiotics and prebiotics do not show significant impact on the amelioration of chronic inflammation-related diseases in general, necessitating the development of next-generation, disease-targeted strains.
Do not rely on over-the-counter, generic probiotics to treat chronic conditions like obesity, diabetes, or IBD. Current evidence shows they generally lack significant impact. Instead, consult healthcare providers for emerging, strain-specific therapies or next-generation probiotics designed for your specific condition.
GoodRefutesHIGH confidence
So far the traditionally prescribed prebiotics and probiotics do not show significant impact on amelioration of these diseases in general. Thus the development of next generation prebiotics and probiotics designed to target specific diseases is urgently needed.
Why this rating
Based on a comprehensive review of multiple clinical settings and heterogeneous study results.
Source
Probiotics, prebiotics and amelioration of diseases
Yu‐Ling Tsai et al. · Journal of Biomedical Science · 2019
DOI 10.1186/s12929-018-0493-6
narrative_reviewCited 400×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Administration of probiotics to critically ill patients with multiorgan failure or severe immunocompromise can increase bacterial translocation and cause sepsis, making it unsafe as a standard practice.Good
- Specific next-generation probiotics and synbiotics (e.g., VSL#3, E. coli Nissle 1917, specific Bifidobacterium strains) show promising or beneficial effects in treating Ulcerative Colitis (UC) and Necrotizing Enterocolitis (NEC), unlike general probiotics.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →